VeritaCell SIA

2018
HealthTech & BioTech
Latvia

Description

The simplest point-of-care surgical kit for faster and better skin regeneration. It is based on a proprietary methodology that allows to quickly extract viable autologous skin cells in large numbers and reapply them onto the wound to heal.

Industry domain

Biotech
Medtech
Healthtech

Investment stage and needs

Strategic partners (wound care / dermatology companies) for co-financing of clinical trials and market entry, marketing authorization, distribution and sales; Experts with deep understanding of the regulations and guidelines for Medical devices / Advanced Therapy Medicinal Products (ATMP); 2M EUR funding for hiring expert team members and carrying out clinical studies.

 

 

Pitch deck

The X2.0 Acceleration Program

Team

Arseniy Sergeyev
CEO
Evija Vascenko
COO
Dr. Nik Georgopoulos
CSO
Dr. Michael Peake
CTO

Would you like to be an Impact Builder?